{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:55:03Z","timestamp":1790294103244,"version":"4.1.0"},"reference-count":52,"publisher":"Scientific Scholar","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Palliat Care"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/0973-1075.285694","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T14:47:30Z","timestamp":1593182850000},"page":"191","source":"Crossref","is-referenced-by-count":4,"title":["Indian society for study of pain, cancer pain special interest group guidelines on pharmacological management of cancer pain (Part III)"],"prefix":"10.25259","volume":"26","author":[{"given":"RaghuS","family":"Thota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghavendra","family":"Ramanjulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parmanand","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushma","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Salins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipasri","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0973-1075.285694-1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/0310057X0503300306","article-title":"Acute pain management pharmacology for the patient with concurrent renal or hepatic disease","author":"Murphy","year":"2005","journal-title":"Anaesth Intensive Care"},{"key":"key-10.4103\/0973-1075.285694-2","first-page":"1","article-title":"Opioid safety in patients with renal or hepatic dysfunction","author":"Johnson","year":"2007","journal-title":"Pain Treat Top"},{"key":"key-10.4103\/0973-1075.285694-3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/0269216308100247","article-title":"Symptom management for the adult patient dying with advanced chronic kidney disease: A review of the literature and development of evidence-based guidelines by a United Kingdom Expert Consensus Group","author":"Douglas","year":"2009","journal-title":"Palliat Med"},{"key":"key-10.4103\/0973-1075.285694-4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jpainsymman.2004.02.021","article-title":"Opioids in renal failure and dialysis patients","author":"Dean","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"key-10.4103\/0973-1075.285694-5","unstructured":"Scottish Intercollegiate Guidelines Network. Control of Pain in Adults with Cancer. Edinburgh: Scottish Intercollegiate Guidelines Network; 2008."},{"key":"key-10.4103\/0973-1075.285694-6","first-page":"5","article-title":"The use of opioid analgesia in end-stage renal disease patients managed without dialysis: Recommendations for practice","author":"Murtagh","year":"2007","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"key-10.4103\/0973-1075.285694-7","unstructured":"Ashmore S. Pain control in renal impairment. In: Ashley C, Morlidge C, editors. Introduction to Renal Therapeutics. London: Pharmaceutical Press; 2008. p. 191-204."},{"key":"key-10.4103\/0973-1075.285694-8","unstructured":"Watson M, Lucas C, Hoy A, Back I, Armstrong P, editors. Palliative Adult Network Guidelines (PANG). 3rd ed. Nine Cancer Networks Across the UK; 2011."},{"key":"key-10.4103\/0973-1075.285694-9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0376-8716(80)90180-5","article-title":"Methadone use in patients with chronic renal disease","author":"Kreek","year":"1980","journal-title":"Drug Alcohol Depend"},{"key":"key-10.4103\/0973-1075.285694-10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jpain.2003.09.007","article-title":"Opioids and renal function","author":"Mercadante","year":"2004","journal-title":"J Pain"},{"key":"key-10.4103\/0973-1075.285694-11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpain.2004.11.009","article-title":"Treatment of pain in patients with renal insufficiency: The World Health Organization three-step ladder adapted","author":"Launay-Vacher","year":"2005","journal-title":"J Pain"},{"key":"key-10.4103\/0973-1075.285694-12","doi-asserted-by":"crossref","first-page":"s17","DOI":"10.1191\/0269216306pm1127oa","article-title":"Renal impairment: A challenge for opioid treatment.The role of buprenorphine?","author":"B\u00f6ger","year":"2006","journal-title":"Palliat Med"},{"key":"key-10.4103\/0973-1075.285694-13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol"},{"key":"key-10.4103\/0973-1075.285694-14","doi-asserted-by":"crossref","unstructured":"Mishra S, Bhatnagar S, Goyal GN, Rana SP, Upadhya SP. A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: A prospective randomized double-blind placebo-controlled study. Am J Hosp Palliat Care 2012;29:177-82.","DOI":"10.1177\/1049909111412539"},{"key":"key-10.4103\/0973-1075.285694-15","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical features of metastatic bone disease and risk of skeletal morbidity","author":"Coleman","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key-10.4103\/0973-1075.285694-16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10549-011-1475-5","article-title":"Survival in breast cancer patients with bone metastases and skeletal-related events: A population-based cohort study in Denmark (1999-2007)","author":"Yong","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"key-10.4103\/0973-1075.285694-17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1939-1676.2004.tb02593.x","article-title":"Bisphosphonates and cancer","author":"Milner","year":"2004","journal-title":"J Vet Intern Med"},{"key":"key-10.4103\/0973-1075.285694-18","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2010.11.026","article-title":"Palliative radiotherapy for bone metastases: An ASTRO evidence-based guideline","author":"Lutz","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key-10.4103\/0973-1075.285694-19","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1200\/JCO.2005.08.193","article-title":"Short-course versus split-course radiotherapy in metastatic spinal cord compression: Results of a phase III, randomized, multicenter trial","author":"Maranzano","year":"2005","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0973-1075.285694-20","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1200\/JCO.2015.64.0862","article-title":"Radiotherapy with 4 Gy\u00d75 Versus 3 Gy\u00d710 for metastatic epidural spinal cord compression: Final results of the SCORE-2 trial (ARO 2009\/01)","author":"Rades","year":"2016","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0973-1075.285694-21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1470-2045(13)70556-4","article-title":"Single versus multiple fractions of repeat radiation for painful bone metastases: A randomised, controlled, non-inferiority trial","author":"Chow","year":"2014","journal-title":"Lancet Oncol"},{"key":"key-10.4103\/0973-1075.285694-22","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijrobp.2012.01.014","article-title":"A 2011 updated systematic review and clinical practice guideline for the management of malignant extradural spinal cord compression","author":"Loblaw","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key-10.4103\/0973-1075.285694-23","doi-asserted-by":"crossref","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","article-title":"Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines","author":"Fallon","year":"2018","journal-title":"Ann Oncol"},{"key":"key-10.4103\/0973-1075.285694-24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.clon.2011.03.003","article-title":"Mechanisms of cancer-induced bone pain","author":"Middlemiss","year":"2011","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"key-10.4103\/0973-1075.285694-25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1749-6632.2010.05766.x","article-title":"The use of bisphosphonates in cancer treatment","author":"Coleman","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.4103\/0973-1075.285694-26","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/cncr.11701","article-title":"Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: A randomized, double-blind, multicenter, comparative trial","author":"Rosen","year":"2003","journal-title":"Cancer"},{"key":"key-10.4103\/0973-1075.285694-27","first-page":"377","article-title":"Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: A phase III, double-blind, comparative trial","author":"Rosen","year":"2001","journal-title":"Cancer J"},{"key":"key-10.4103\/0973-1075.285694-28","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: A randomized, double-blind study","author":"Stopeck","year":"2010","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0973-1075.285694-29","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/jnci\/djh141","article-title":"Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer","author":"Saad","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"key-10.4103\/0973-1075.285694-30","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/cncr.20308","article-title":"Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: A randomized, Phase III, double-blind, placebo-controlled trial","author":"Rosen","year":"2004","journal-title":"Cancer"},{"key":"key-10.4103\/0973-1075.285694-31","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S1470-2045(11)70157-7","article-title":"Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): Secondary outcomes from a randomised controlled trial","author":"Morgan","year":"2011","journal-title":"Lancet Oncol"},{"key":"key-10.4103\/0973-1075.285694-32","first-page":"CD002068","article-title":"Bisphosphonates for the relief of pain secondary to bone metastases","author":"Wong","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0973-1075.285694-33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0269216316639793","article-title":"Evidence on the analgesic role of bisphosphonates and denosumab in the treatment of pain due to bone metastases: A systematic review within the European Association for Palliative Care guidelines project","author":"Porta-Sales","year":"2017","journal-title":"Palliat Med"},{"key":"key-10.4103\/0973-1075.285694-34","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: A randomised, double-blind study","author":"Fizazi","year":"2011","journal-title":"Lancet"},{"key":"key-10.4103\/0973-1075.285694-35","doi-asserted-by":"crossref","first-page":"iii124","DOI":"10.1093\/annonc\/mdu103","article-title":"Bone health in cancer patients: ESMO Clinical Practice Guidelines","author":"Coleman","year":"2014","journal-title":"Ann Oncol"},{"key":"key-10.4103\/0973-1075.285694-36","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/annonc\/mdm442","article-title":"Guidance on the use of bisphosphonates in solid tumours: Recommendations of an international expert panel","author":"Aapro","year":"2008","journal-title":"Ann Oncol"},{"key":"key-10.4103\/0973-1075.285694-37","first-page":"CD003347","article-title":"WITHDRAWN: Radioisotopes for metastatic bone pain","author":"Roqu\u00e9","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0973-1075.285694-38","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S1470-2045(14)70183-4","article-title":"Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: Results from a phase 3, double-blind, randomised trial","author":"Sartor","year":"2014","journal-title":"Lancet Oncol"},{"key":"key-10.4103\/0973-1075.285694-39","first-page":"S21","article-title":"Pharmacologic management of cancer pain","author":"Pharo","year":"2005","journal-title":"J Am Osteopath Assoc"},{"key":"key-10.4103\/0973-1075.285694-40","first-page":"CD010756","article-title":"Corticosteroids for the management of cancerrelated pain in adults","author":"Haywood","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0973-1075.285694-41","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1200\/JCO.2013.54.3926","article-title":"Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: A randomized, placebo-controlled, double-blind trial","author":"Paulsen","year":"2014","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0973-1075.285694-42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1049909106295431","article-title":"A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients","author":"Mercadante","year":"2007","journal-title":"Am J Hosp Palliat Care"},{"key":"key-10.4103\/0973-1075.285694-43","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jpainsymman.2012.06.019","article-title":"Do corticosteroids provide analgesic effects in cancer patients.A systematic literature review?","author":"Paulsen","year":"2013","journal-title":"J Pain Symptom Manage"},{"key":"key-10.4103\/0973-1075.285694-44","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1007\/s00520-018-4339-2","article-title":"Side effects of corticosteroids in patients with advanced cancer: A systematic review","author":"Hatano","year":"2018","journal-title":"Support Care Cancer"},{"key":"key-10.4103\/0973-1075.285694-45","doi-asserted-by":"crossref","unstructured":"Petrenko AB, Yamakura T, Baba H, Shimoji K. The role of N-methyl-D-aspartate (NMDA) receptors in pain: A review. Anesth Analg 2003;97:1108-16.","DOI":"10.1213\/01.ANE.0000081061.12235.55"},{"key":"key-10.4103\/0973-1075.285694-46","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1213\/01.ANE.0000086618.28845.9B","article-title":"Ketamine in chronic pain management: An evidence-based review","author":"Hocking","year":"2003","journal-title":"Anesth Analg"},{"key":"key-10.4103\/0973-1075.285694-47","doi-asserted-by":"crossref","unstructured":"Jonkman K, van de Donk T, Dahan A. Ketamine for cancer pain: What is the evidence? Curr Opin Support Palliat Care 2017;11:88-92.","DOI":"10.1097\/SPC.0000000000000262"},{"key":"key-10.4103\/0973-1075.285694-48","first-page":"CD003351","article-title":"Ketamine as an adjuvant to opioids for cancer pain","author":"Bell","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0973-1075.285694-49","doi-asserted-by":"crossref","unstructured":"Fallon MT, Wilcock A, Kelly CA, Paul J, Lewsley LA, Norrie J, et al. Oral ketamine vs. placebo in patients with cancer-related neuropathic pain: A randomized clinical trial. JAMA Oncol 2018;4:870-2.","DOI":"10.1001\/jamaoncol.2018.0131"},{"key":"key-10.4103\/0973-1075.285694-50","doi-asserted-by":"crossref","unstructured":"Salas S, Frasca M, Planchet-Barraud B, Burucoa B, Pascal M, Lapiana JM, et al. Ketamine analgesic effect by continuous intravenous infusion in refractory cancer pain: Considerations about the clinical research in palliative care. J Palliat Med 2012;15:287-93.","DOI":"10.1089\/jpm.2011.0353"},{"key":"key-10.4103\/0973-1075.285694-51","first-page":"1187","article-title":"Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: A randomized, double- blind, controlled clinical trial","author":"Mystakidou","year":"2002","journal-title":"Anticancer Res"},{"key":"key-10.4103\/0973-1075.285694-52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0885-3924(99)00147-5","article-title":"Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: A prospective randomized trial","author":"Ripamonti","year":"2000","journal-title":"J Pain Symptom Manage"}],"container-title":["Indian Journal of Palliative Care"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T06:52:12Z","timestamp":1691218332000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpalliativecare.com\/indian-society-for-study-of-pain-cancer-pain-special-interest-group-guidelines-on-pharmacological-management-of-cancer-pain-part-iii\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"alternative-id":["285694"],"URL":"https:\/\/doi.org\/10.4103\/0973-1075.285694","relation":{},"ISSN":["0973-1075"],"issn-type":[{"value":"0973-1075","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}